Personalized Medicine: An Idea Whose Time is Approaching
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, April 23, 2009
Einstein, Forchheimer Building, 1st Floor Lecture Hall
MMC, Cherkasky Auditorium
Robert Roberts, MD
President and CEO, University of Ottawa Heart Institute
Director of The Ruddy Canadian Cardiovascular Genetics Centre
Dr. Robert Roberts’ current research is the application of molecular biology and recombinant DNA techniques. He has identified several genes causing familial cardiomyopathies, atrial fibrillation, and WPW syndrome. Developing genetic animal models, he elucidated the pathophysiology and developed new therapies. As Director of the Ruddy Canadian Cardiovascular Genetics Centre, he is pursuing genome-wide association studies to identify genes for Coronary Artery Disease (CAD). He recently (2007) co-authored a publication in Science, which located the first common gene for CAD.
Dr. Roberts received his MD from Dalhousie University, followed by a fellowship at the University of Toronto and a research fellowship at the University of California. He was recruited to Washington University where he attained Associate Professor of Medicine. From 1982 to 2004, he was Chief of Cardiology at Baylor College of Medicine. On April 1, 2004, he was appointed President and CEO of the University of Ottawa Heart Institute and Director of The Ruddy Canadian Cardiovascular Genetics Centre.
Dr. Roberts received the Distinguished Scientist Award from the American College of Cardiology (1998), and the Award of Meritorious Achievement (2001) and the McLaughlin Award from the Royal Society of Canada (2008). He has over 700 publications including Associate Editor of Hurst's The Heart, (1989-present). He was awarded the Most Highly Cited Researcher (2002). He has lectured throughout the world, including several notable plenary addresses.
Medicine Grand Rounds this week is hosted by the Division of Cardiology.
After attending this activity, participants will be able to:
Understand the mechanisms utilized to identify genes responsible for monogenic disorders
Understand the mechanisms utilized to identify genes responsible for polygenic disorders
Understand personalized medicine and be provided with an update on our progress
Understand the first common genetic variant predisposing one to coronary artery disease, namely, 9p21
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.